Rare Disease Day 2026
Improving recognition, diagnosis, and management of rare dyslipidaemias
Rare lipid disorders, such as homozygous familial hypercholesterolaemia (HoFH) and familial chylomicronaemia syndrome (FCS), are serious and often underdiagnosed conditions associated with high cardiovascular and metabolic risk. Early identification and specialised management are essential to improving patient outcomes.
On the occasion of Rare Disease Awareness Day, February 28, we have brought together key resources and learning opportunities on rare lipid disorders:
- through our comprehensive Advanced Course on Rare Lipid Disorders, covering diagnosis, genetics, and management of rare lipid disorders, EAS members can earn UEMS-EACCME accredited CME points — a valuable member benefit.
- in addition, we provide open access to Congress sessions & webinars,
- relevant articles from Atherosclerosis,
- and a wide range of other resources to raise awareness and support education on rare diseases.
This page brings together essential EAS educational resources, scientific publications, and accredited learning opportunities to support clinicians, researchers, and healthcare professionals.
Read more